Does Biological Sex Matter in Lyme Disease? The Need for Sex-Disaggregated Data in Persistent Illness

References

• Blair ML. Sex-based differences in physiology: what should we teach in the medical curriculum? Adv Physiol Educ. 2007;31:23–25. doi:10.1152/advan.00118.2006
   PubMed Web of Science ®Google Scholar
• Arnegard ME, Whitten LA, Hunter C, Clayton JA. Sex as a biological variable: a 5-year progress report and call to action. J Womens Health. 2020;29:858–864. doi:10.1089/jwh.2019.8247
   PubMed Web of Science ®Google Scholar
• Rebman A, Soloski M, Aucott J. Sex and Gender Impact Lyme Disease Immunopathology, Diagnosis and Treatment. In: Klein S, Roberts C, editors. Sex and Gender Differences in Infection and Treatments for Infectious Diseases. Switzerland: Springer International Publishing; 2015. doi:10.1007/978-3-319-16438-0_12.
   Google Scholar
• Kugeler KJ, Schwartz AM, Delorey MJ, Mead PS, Hinckley AF. Estimating the frequency of lyme disease diagnoses, United States, 2010–2018. Emerg Infect Dis. 2021;27:616–619. doi:10.3201/eid2702.202731
   PubMed Web of Science ®Google Scholar
• Schwartz AM, Kugeler KJ, Nelson CA, Marx GE, Hinckley AF. Use of commercial claims data for evaluating trends in lyme disease diagnoses, United States, 2010–2018. Emerg Infect Dis. 2021;27:499–507. doi:10.3201/eid2702.202728
   PubMed Web of Science ®Google Scholar
• Aucott JN, Yang T, Yoon I, Powell D, Geller SA, Rebman AW. Risk of post-treatment Lyme disease in patients with ideally-treated early Lyme disease: a prospective cohort study. InterJ Infect Dis. 2022;116:230–237. doi:10.1016/j.ijid.2022.01.033
   PubMed Web of Science ®Google Scholar
• Hirsch AG, Poulsen MN, Nordberg C, et al. Risk factors and outcomes of treatment delays in lyme disease: a population-based retrospective cohort study. Front Med. 2020;7. doi:10.3389/fmed.2020.560018
   Web of Science ®Google Scholar
• Rebman AW, Bechtold KT, Yang T, et al. The clinical, symptom, and quality-of-life characterization of a well-defined group of patients with posttreatment lyme disease syndrome. Front Med. 2017;4. doi:10.3389/fmed.2017.00224
   Web of Science ®Google Scholar
• Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008;70:992–1003. doi:10.1212/01.WNL.0000284604.61160.2d
   PubMed Web of Science ®Google Scholar
• Johnson L, Shapiro M, Mankoff J. Removing the mask of average treatment effects in chronic Lyme disease research using Big Data and subgroup analysis. Healthcare. 2018;6. doi:10.3390/healthcare6040124
   Web of Science ®Google Scholar
• Klempner M, Hu L, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 2001;345:85–92. doi:10.1056/NEJM200107123450202
   PubMed Web of Science ®Google Scholar
• Krupp LB, Hyman LG, Grimson R, et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology. 2003;60:1923–1930. doi:10.1212/01.WNL.0000071227.23769.9E
   PubMed Web of Science ®Google Scholar
• Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089–1134. doi:10.1086/508667
   PubMed Web of Science ®Google Scholar
• Citera M, Freeman PR, Horowitz RI. Empirical validation of the Horowitz multiple systemic infectious disease syndrome questionnaire for suspected lyme disease. Int J Gen Med. 2017;10:249–273. doi:10.2147/IJGM.S140224
   PubMed Web of Science ®Google Scholar
• Donta ST. Tetracycline therapy for chronic Lyme disease. Clin Infect Dis. 1997;25(1):S52–56. doi:10.1086/516171
   PubMedGoogle Scholar
• Donta ST. Macrolide therapy of chronic Lyme Disease. Med Sci Monit. 2003;9:I136–142.
   Google Scholar
• Rebman AW, Crowder LA, Kirkpatrick A, Aucott JN. Characteristics of seroconversion and implications for diagnosis of post-treatment Lyme disease syndrome: acute and convalescent serology among a prospective cohort of early Lyme disease patients. Clin Rheumatol. 2015;34:585–589. doi:10.1007/s10067-014-2706-z
   PubMed Web of Science ®Google Scholar
• Wormser GP, Shapiro ED. Implications of gender in chronic Lyme disease. J Womens Health. 2009;18:831–834. doi:10.1089/jwh.2008.1193
   Web of Science ®Google Scholar
• Schwartz AM, Hinckley AF, Mead PS, Hook SA, Kugeler KJ. Surveillance for Lyme Disease - United States, 2008–2015. MMWR Surveill Summ. 2017;66:1–12. doi:10.15585/mmwr.ss6622a1
   PubMed Web of Science ®Google Scholar
• Johnson L, Shapiro M, Stricker RB, Vendrow J, Haddock J, Needell D. Antibiotic treatment response in chronic lyme disease: why do some patients improve while others do not? Healthcare. 2020;8. doi:10.3390/healthcare8040383
   Web of Science ®Google Scholar
• Johnson L, Wilcox S, Mankoff J, Stricker RB. Severity of chronic Lyme disease compared to other chronic conditions: a quality of life survey. In PeerJ. 2014;2:e322. doi:10.7717/peerj.322
   PubMed Web of Science ®Google Scholar
• Vendrow J, Haddock J, Needell D, Johnson L. Feature selection from lyme disease patient survey using machine learning. Algorithms. 2020;13:334. doi:10.3390/a13120334
   Web of Science ®Google Scholar
• Gliklich R, Leavy DN. Registries for Evaluating Patient Outcomes: A User’s Guide. 3rd ed. Rockville, MD: Agency for Healthcare Research and Quality; 2014.
   Google Scholar
• Scotti JM. Sex Differences in Lyme Disease Symptomatology in the Northeast United States. Walden University; 2020.
   Google Scholar
• Aucott JN. Personal Communication. Email “Re: your 2022 Study”. (PTLD unpublished data for 32 patients). Received by L. Johnson; 2022.
   Google Scholar
• Fallon BA, Petkova E, Keilp J, Britton C. A reappraisal of the U.S. clinical trials of post-treatment lyme disease syndrome. Open Neurol J. 2012;6:79–87. doi:10.2174/1874205X01206010079
   PubMedGoogle Scholar
• Horn EJ, Dempsey G, Schotthoefer AM, et al. The Lyme disease biobank: characterization of 550 patient and control samples from the east coast and upper midwest of the United States. J Clin Microbiol. 2020;58. doi:10.1128/jcm.00032-20
   PubMed Web of Science ®Google Scholar
• Horn EJ. Personal Communication. Email “Re: gender in LDB”. (PLD/CLD unpublished data for 73 patients). Received by L. Johnson; 2022.
   Google Scholar
• Centers for Disease Control and Prevention. Summary Health Statistics: National Health Interview Survey, 2018. Age-adjusted percent distribution (with standard errors) of work-loss days in the past 12 months among employed adults aged 18 and over, and age-adjusted percent distribution (with standard errors) of bed days in the past 12 months among all adults aged 18 and over, by selected characteristics: United States; 2018. Availabe from: https://ftp.cdc.gov/pub/Health_Statistics/NCHS/NHIS/SHS/2018_SHS_Table_A-9.pdf. Accessed September 29, 2022.
   Google Scholar
• Kaiser Family Foundation. Adult self-reported health status analysis of the centers for disease control and prevention (CDC)’s 2020 Behavioral Risk Factor Surveillance System (BRFSS). Timeframe; 2020. Availabe from: https://www.kff.org/other/state-indicator/adult-self-reported-healthstatus/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D. Accessed September 23, 2022.
   Google Scholar
• S.C. Department of Health and Environmental Control (DHEC). BRFSS SC: health problems requiring special equipment; 2014. Availabe from: https://scdhec.gov/sites/default/files/docs/Health/docs/BRFSSreports/2015/8-C.pdf. Accessed September 29, 2022.
   Google Scholar
• DeSalvo KB, Fan VS, McDonell MB, Fihn SD. Predicting mortality and healthcare utilization with a single question. Health Serv Res. 2005;40:1234–1246. doi:10.1111/j.1475-6773.2005.00404.x
   PubMed Web of Science ®Google Scholar
• Dias SP, Brouwer MC, van de Beek D. Sex and gender differences in bacterial infections. Infect Immun. 2022;e0028322. doi:10.1128/iai.00283-22
   PubMed Web of Science ®Google Scholar
• Vom Steeg LG, Klein SL. SeXX matters in infectious disease pathogenesis. PLoS Pathog. 2016;12:e1005374–e1005374. doi:10.1371/journal.ppat.1005374
   PubMed Web of Science ®Google Scholar
• Shansky RM, Murphy AZ. Considering sex as a biological variable will require a global shift in science culture. Nat Neurosci. 2021;24:457–464. doi:10.1038/s41593-021-00806-8
   PubMed Web of Science ®Google Scholar
• Mehta LS, Beckie TM, DeVon HA, et al. Acute Myocardial Infarction in Women. Circulation. 2016;133:916–947. doi:10.1161/CIR.0000000000000351
   PubMed Web of Science ®Google Scholar
• Banco D, Chang J, Talmor N, et al. Sex and race differences in the evaluation and treatment of young adults presenting to the emergency department with chest pain. J Am Heart Assoc. 2022;11:e024199. doi:10.1161/JAHA.121.024199
   PubMed Web of Science ®Google Scholar
• Maserejian NN, Link CL, Lutfey KL, Marceau LD, McKinlay JB. Disparities in physicians’ interpretations of heart disease symptoms by patient gender: results of a video vignette factorial experiment. J Womens Health. 2009;18:1661–1667. doi:10.1089/jwh.2008.1007
   PubMed Web of Science ®Google Scholar
• Rebman AW, Yang T, Mihm EA, et al. The presenting characteristics of erythema migrans vary by age, sex, duration, and body location. Infection. 2021;49:685–692. doi:10.1007/s15010-021-01590-0
   PubMed Web of Science ®Google Scholar
• Feder HM Jr, Gerber MA, Luger SW, Ryan RW. Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease. Clin Infect Dis. 1992;15:788–793. doi:10.1093/clind/15.5.788
   PubMed Web of Science ®Google Scholar
• Schwarzwalder A, Schneider MF, Lydecker A, Aucott JN. Sex differences in the clinical and serologic presentation of early Lyme disease: results from a retrospective review. Gend Med. 2010;7:320–329. doi:10.1016/j.genm.2010.08.002
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. What is ME/CFS? Availabe from: https://www.cdc.gov/me-cfs/about/index.html. Accessed September 23, 2022.
   Google Scholar
• National Center for Complementary and Integrative Health. Fibromyalgia: in Depth. Availabe from: https://www.nccih.nih.gov/health/fibromyalgia-in-depth. Accessed September 23, 2022.
   Google Scholar
• Cairns V, Godwin J. Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. Int J Epidemiol. 2005;34:1340–1345. doi:10.1093/ije/dyi129
   PubMed Web of Science ®Google Scholar
• National Institute of Arthritis and Musculoskeletal and Skin Diseases. Fibromyalgia: diagnosis, treatment, and steps to take. Availabe from: https://www.niams.nih.gov/health-topics/fibromyalgia/diagnosis-treatment-and-steps-to-take. Accessed September 23, 2022.
   Google Scholar
• Adrion ER, Aucott J, Lemke KW, Weiner JP. Health care costs, utilization and patterns of care following Lyme disease. PLoS One. 2015;10:e0116767. doi:10.1371/journal.pone.0116767
   PubMed Web of Science ®Google Scholar
• Ursinus J, Vrijmoeth HD, Harms MG, et al. Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study. Lancet Reg Health. 2021;6:100142. doi:10.1016/j.lanepe.2021.100142
   PubMedGoogle Scholar
• Biau DJ, Kernéis S, Porcher R. Statistics in brief: the importance of sample size in the planning and interpretation of medical research. Clin Orthop Relat Res. 2008;466:2282–2288. doi:10.1007/s11999-008-0346-9
   PubMed Web of Science ®Google Scholar
• Jarefors S, Bennet L, You E, et al. Lyme borreliosis reinfection: might it be explained by a gender difference in immune response? Immunology. 2006;118:224–235. doi:10.1111/j.1365-2567.2006.02360.x
   PubMed Web of Science ®Google Scholar
• Vanderwall AG, Milligan ED. Cytokines in pain: harnessing endogenous anti-inflammatory signaling for improved pain management. Front Immunol. 2019;10:3009. doi:10.3389/fimmu.2019.03009
   PubMed Web of Science ®Google Scholar
• Heidari S, Babor TF, De Castro P, Tort S, Curno M. Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use. Res Integr Peer Rev. 2016;1:2. doi:10.1186/s41073-016-0007-6
   PubMedGoogle Scholar
• Sylvester SV, Rusu R, Chan B, Bellows M, O’Keefe C, Nicholson S. Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review. Curr Med Res Opin. 2022;38:1391–1399. doi:10.1080/03007995.2022.2081454
   PubMed Web of Science ®Google Scholar
• Bai F, Tomasoni D, Falcinella C, et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2022;28:611.e619–611.e616. doi:10.1016/j.cmi.2021.11.002
   Web of Science ®Google Scholar
• Dreyer N, Franklin P, Haynes K. Direct-to-Patient Registry and Other Patient-Centric Designs. In: Century Patient Registries: Registries for Evaluating Patient Outcomes: A User’s Guide. 3rd ed. Gliklich RE, Dreyer NA, Leavy MB, editors. Rockville (MD): Agency for Healthcare Research and Quality; 2018:4.
   Google Scholar
• Howie L, Hirsch B, Locklear T, Abernethy AP. Assessing the value of patient-generated data to comparative effectiveness research. Health Aff. 2014;33:1220–1228. doi:10.1377/hlthaff.2014.0225
   PubMed Web of Science ®Google Scholar
• Fowler FJ Jr, Cosenza C, Cripps LA, Edgman-Levitan S, Cleary PD. The effect of administration mode on CAHPS survey response rates and results: a comparison of mail and web-based approaches. Health Serv Res. 2019;54:714–721. doi:10.1111/1475-6773.13109
   PubMed Web of Science ®Google Scholar
• Pratap A, Neto EC, Snyder P, et al. Indicators of retention in remote digital health studies: a cross-study evaluation of 100,000 participants. npj Dig Med. 2020;3:21. doi:10.1038/s41746-020-0224-8
   PubMed Web of Science ®Google Scholar
• Bayliss M, Rendas-Baum R, White MK, Maruish M, Bjorner J, Tunis SL. Health-related quality of life (HRQL) for individuals with self-reported chronic physical and/or mental health conditions: panel survey of an adult sample in the United States. Health Qual Life Outcomes. 2012;10:154.
   PubMed Web of Science ®Google Scholar